David Paterson

David Paterson serves as a Postdoctoral Research Associate at the University of Glasgow's School of Cardiovascular & Metabolic Health, focusing on interdisciplinary biomedical research that bridges immunology, nanomedicine, and biophysical systems. His work demonstrates strong integration of engineering principles with biological applications.

His research interests center on nanoparticle drug delivery systems, membrane biophysics, and inflammatory disease mechanisms. Paterson's work explores how nanoscale interventions can modulate immune responses, particularly in rheumatoid arthritis, while also investigating fundamental membrane interactions with antimicrobial peptides and engineered vesicles.

Analysis of his publication record reveals consistent focus on translational biomedical engineering approaches, with recent work (2024) demonstrating therapeutic applications for rheumatoid arthritis, while earlier publications established foundational work in membrane biophysics and microfluidic systems. His research trajectory shows progression from fundamental biophysical studies toward clinically relevant applications.

Paterson has collaborated extensively with researchers including Tassieri, Reboud, Wilson, and Cooper across multiple publications, indicating strong interdisciplinary network within the University of Glasgow's biomedical research community.